USD 7.0
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.03 USD | 37.25% |
2022 | -0.05 USD | -598.72% |
2021 | -0.01 USD | 82.19% |
2020 | -0.04 USD | 63.5% |
2019 | -0.12 USD | 47.83% |
2018 | -0.23 USD | 57.41% |
2017 | -0.54 USD | 0.0% |
2009 | -4.82 USD | 32.68% |
2008 | -7.16 USD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2023 Q4 | -0.02 USD | -164.29% |
2023 Q1 | -0.01 USD | 77.15% |
2023 Q3 | -0.01 USD | -84.21% |
2023 Q2 | -0.00 USD | 37.7% |
2022 FY | - USD | -598.72% |
2022 Q2 | -0.01 USD | 0.0% |
2022 Q3 | -0.00 USD | 18.97% |
2022 Q4 | -0.03 USD | -468.09% |
2022 Q1 | -0.01 USD | 1.69% |
2021 Q2 | -0.00 USD | -241.38% |
2021 FY | - USD | 82.19% |
2021 Q4 | -0.01 USD | 7.81% |
2021 Q3 | -0.01 USD | -56.1% |
2021 Q1 | 0.00 USD | 163.04% |
2020 Q3 | -0.01 USD | 61.36% |
2020 Q2 | -0.01 USD | 36.54% |
2020 FY | - USD | 63.5% |
2020 Q1 | -0.02 USD | -45.45% |
2020 Q4 | -0.00 USD | 9.8% |
2019 Q2 | -0.02 USD | 46.19% |
2019 FY | - USD | 47.83% |
2019 Q4 | -0.01 USD | 63.52% |
2019 Q3 | -0.04 USD | -58.7% |
2019 Q1 | -0.05 USD | -427.59% |
2018 Q4 | -0.01 USD | 0.0% |
2018 FY | - USD | 57.41% |
2017 FY | - USD | 0.0% |
2010 Q1 | -1.91 USD | -36630.77% |
2010 Q2 | -1.02 USD | 46.6% |
2009 FY | - USD | 32.68% |
2009 Q4 | -0.01 USD | 0.0% |
2009 Q2 | -1.53 USD | -68.13% |
2009 Q1 | -0.91 USD | 0.0% |
2008 FY | - USD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
America Great Health | - USD | Infinity% |
Gene Biotherapeutics, Inc. | - USD | Infinity% |
Evolutionary Genomics, Inc. | -0.35 USD | 90.229% |
Innovation1 Biotech Inc. | -0.70 USD | 95.114% |
Point of Care Nano-Technology, Inc. | -0.10 USD | 65.8% |